Alistair's Feed
Apr 30, 2015

European shares post first monthly fall of 2015 after Nokia drop

LONDON, April 30 (Reuters) – A selloff in technology stocks,
after disappointing numbers from Nokia, weighed on
European shares on Thursday as a pan-European benchmark index
marked its first monthly fall this year.

However, most national euro zone indexes were in positive
territory after data showed deflation had ended, persuading
investors that monetary easing by the European Central Bank was
having an effect.

Apr 30, 2015

European shares set for 2015′s first monthly fall after Nokia drop

LONDON, April 30 (Reuters) – A selloff in technology stocks
weighed on European shares on Thursday after disappointing
numbers from Nokia, leaving a top pan-European equity
index set for its first monthly fall this year.

Shares in Finnish firm Nokia fell 8.2 percent after it
posted quarterly profits well below forecast at its main telecom
network equipment business, citing lower software sales, higher
costs and challenging conditions in Europe and Latin America.

Apr 29, 2015

Britain’s FTSE steadies near highs after mixed earnings

LONDON, April 29 (Reuters) – Britain’s top share index
stayed within reach of all-time highs on Wednesday as traders
digested mixed earnings news on a busy day of corporate updates.

Weak numbers from the likes of British American Tobacco
were partly counteracted by a boost from
better-than-expected results from Next and others.

Apr 29, 2015

Mixed earnings see FTSE steady near all-time highs

LONDON (Reuters) – FTSE stayed within reach of all-time highs on Wednesday as traders digested mixed earnings news on a busy day of corporate updates.

Weak numbers from the likes of British American Tobacco were partly counteracted by a boost from better-than-expected results from the likes of Next.

Apr 29, 2015

Mixed earnings see Britain’s FTSE steady near all-time highs

LONDON, April 29 (Reuters) – Britain’s top share index
stayed within reach of all-time highs on Wednesday as traders
digested mixed earnings news on a busy day of corporate updates.

Weak numbers from the likes of British American Tobacco
were partly counteracted by a boost from
better-than-expected results from the likes of Next.

Apr 28, 2015

Britain’s FTSE falls after weak corporate updates, U.S. data

LONDON, April 28 (Reuters) – Britain’s top share index faced
its biggest one-day drop in nearly a month on Tuesday, weighed
down by a combination of disappointing corporate updates and
weak U.S. data.

The FTSE 100 was down 93.56 points, or 1.3 percent,
at 7,010.42 points at 1452 GMT, retreating from a record high of
7,122.74 hit on Monday.

Apr 28, 2015

As Britain’s election looms, stock-market wobbles appear

LONDON, April 28 (Reuters) – With Britain’s most
unpredictable general election in decades just over a week away,
investors and traders are bracing for wobbles on a stock market
that up until now has soundly shrugged off political risk.

Britons head to the polls on May 7, and barometers of stock
market volatility are beginning to rise while domestically
exposed stocks underperform as polling data and campaign
developments build up twitchiness on dealing desks.

Apr 28, 2015

AstraZeneca’s slide drags Britain’s FTSE away from all-time high

LONDON, April 28 (Reuters) – Britain’s top share index
pulled away from all-time highs on Tuesday, weighed down by a
drop in drugs firm AstraZeneca and Asia-focused bank
Standard Charted.

Weaker-than-expected UK economic output data helped the FTSE
100 edge off its early lows, however, as it knocked down
the pound, making British blue chips’ exports more attractive.

Apr 28, 2015

AstraZeneca’s slide helps push FTSE away from all-time high

LONDON (Reuters) – FTSE pulled away from all-time highs on Tuesday, weighed down by a drop in pharmaceutical stocks, although the market was supported by forecast-beating results from oil giant BP.

AstraZeneca was the top faller on the FTSE 100, sliding 1.7 percent after U.S. rival Merck & Co’s diabetes drug met heart-safety requirements in a recent study.

Apr 28, 2015

AstraZeneca’s slide helps push Britain’s FTSE away from all-time high

LONDON, April 28 (Reuters) – Britain’s top share index
pulled away from all-time highs on Tuesday, weighed down by a
drop in pharmaceutical stocks, although the market was supported
by forecast-beating results from oil giant BP.

AstraZeneca was the top faller on the FTSE 100
, sliding 1.7 percent after U.S. rival Merck & Co’s
diabetes drug met heart-safety requirements in a recent
study.

    • About Alistair

      "Alistair Smout is working on the Investment and Emerging Markets for Reuters Europe over the summer. He specialises in Africa and Europe."
    • More from Alistair

    • Follow Alistair